WEG
WST icon

World Equity Group’s West Pharmaceutical WST Stock Holding History

World Equity Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,952
Closed -$359K – 579
2023
Q1 		$359K Buy
+3,952
New +$1.15M 0.05% 332

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

World Equity Group's WST Position: Q2 2023 in Review

World Equity Group sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 3,952 shares — an estimated $359K sold.

World Equity Group first reported a position in WST in Q1 2023 and held it in 1 quarter. The position peaked at $359K in Q1 2023. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • World Equity Group reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • World Equity Group sold 3,952 West Pharmaceutical shares in Q2 2023, an estimated $359K.
  • World Equity Group first reported a position in West Pharmaceutical in Q1 2023 and held it in 1 quarter.
  • World Equity Group's West Pharmaceutical position peaked at $359K in Q1 2023.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on World Equity Group's 13F filing for Q2 2023, filed 26 Aug 2024.